Separation and detection methods for covalent drug-protein adducts.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

• Publication date

  2003-11-25

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S1570-0232(03)00399-4PMID 14630144
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Resolution of human mercapt- and nonmercaptalbumin by high-performance liquid chromatography.

  2009cited by this paper
• Gas chromatography-mass spectrometry determination of ethylenethiourea hemoglobin adducts: a possible indicator of exposure to ethylene bis dithiocarbamate pesticides

  2009cited by this paper
• Prediction of toxicity from chemical structure

  2004cited by this paper
• Update on clinical role of tamoxifen

  2003cited by this paper
• Analysis of DNA and protein adducts of benzo[a]pyrene in human tissues using structure-specific methods.

  2003cited by this paper
• Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts.

  2003cited by this paper
• The second generation of COX-2 inhibitors: what advantages do the newest offer?

  2003cited by this paper
• The integration of data on physico-chemical properties, in vitro-derived toxicity data and physiologically based kinetic and dynamic as modelling a tool in hazard and risk assessment. A commentary.

  2003cited by this paper
• Immunopharmacology of hypersensitivity reactions to drugs

  2003cited by this paper
• Acyl Glucuronide Drug Metabolites: Toxicological and Analytical Implications

  2003cited by this paper
• Substrate selectivity of human cytochrome P450 2C9: importance of residues 476, 365, and 114 in recognition of diclofenac and sulfaphenazole and in mechanism-based inactivation by tienilic acid.

  2003cited by this paper
• Identification and quantification of in vitro adduct formation between protein reactive xenobiotics and a lysine‐containing model peptide

  2003cited by this paper
• Measurement of hemoglobin and albumin adducts of naphthalene-1,2-oxide, 1,2-naphthoquinone and 1,4-naphthoquinone after administration of naphthalene to F344 rats.

  2002cited by this paper
• Identification of human CYP forms involved in the activation of tamoxifen and irreversible binding to DNA.

  2002cited by this paper
• A review of the common properties of drugs with idiosyncratic hepatotoxicity and the "multiple determinant hypothesis" for the manifestation of idiosyncratic drug toxicity.

  2002cited by this paper
• Xenobiotic acyl glucuronides and acyl CoA thioesters as protein-reactive metabolites with the potential to cause idiosyncratic drug reactions.

  2002cited by this paper
• Pathways of carbamazepine bioactivation in vitro I. Characterization of human cytochromes P450 responsible for the formation of 2- and 3-hydroxylated metabolites.

  2002cited by this paper
• The danger hypothesis--potential role in idiosyncratic drug reactions.

  2002cited by this paper
• Mechanisms of hepatotoxicity.

  2002cited by this paper
• Over-the-counter Analgesics: A Toxicologic Perspective

  2002cited by this paper
• Practical aspects of the ligand-binding and enzymatic properties of human serum albumin.

  2002cited by this paper
• Hepatotoxicity of Commonly Used Drugs: Nonsteroidal Anti-Inflammatory Drugs, Antihypertensives, Antidiabetic Agents, Anticonvulsants, Lipid-Lowering Agents, Psychotropic Drugs

  2002cited by this paper
• Protein adducts: quantitative and qualitative aspects of their formation, analysis and applications.

  2002cited by this paper
• Determination of acetaminophen-protein adducts in mouse liver and serum and human serum after hepatotoxic doses of acetaminophen using high-performance liquid chromatography with electrochemical detection.

  2002cited by this paper
• Sensitivity to nonsteroidal anti-inflammatory drugs.

  2002cited by this paper
• Theoretical and computational advances in biomolecular NMR spectroscopy.

  2002cited by this paper
• Rapid internal acyl migration and protein binding of synthetic probenecid glucuronides.

  2002cited by this paper
• Multiple mechanisms in indomethacin-induced impairment of hepatic cytochrome P450 enzymes in rats.

  2002cited by this paper
• Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes: formation of the 4-hydroxy, 4'-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen.

  2002cited by this paper
• The International Sepsis Forum's controversies in sepsis: corticosteroids should be used to treat septic shock

  2002cited by this paper
• Two-dimensional gel electrophoresis: recent advances in sample preparation, detection and quantitation.

  2002cited by this paper
• Human CYPs: in vivo and clinical aspects

  2002cited by this paper
• 4‐Hydroxytamoxifen sulfation metabolism

  2002cited by this paper
• Metabolite analysis, isolation and purity assessment using various liquid chromatographic techniques combined with radioactivity detection.

  2002cited by this paper
• Early discovery drug screening using mass spectrometry.

  2002cited by this paper
• Electrospray low energy CID and MALDI PSD fragmentations of protonated sulfinamide cross-linked peptides

  2002cited by this paper
• On the diversity of oxidative bioactivation reactions on nitrogen-containing xenobiotics.

  2002cited by this paper
• Drug‐plasma protein binding assay by electrokinetic chromatography‐frontal analysis

  2002cited by this paper
• Autoantibodies Associated with Volatile Anesthetic Hepatitis Found in the Sera of a Large Cohort of Pediatric Anesthesiologists

  2002cited by this paper
• Inhibition of tubulin assembly and covalent binding to microtubular protein by valproic acid glucuronide in vitro.

  2002cited by this paper
• Bioactivation of tamoxifen by recombinant human cytochrome p450 enzymes.

  2002cited by this paper
• Cysteine-modifying agents: a possible approach for effective anticancer and antiviral drugs.

  2002cited by this paper
• Mechanism of idiosyncratic drug reactions: reactive metabolite formation, protein binding and the regulation of the immune system.

  2002cited by this paper
• Pharmacology of systemic analgesics.

  2002cited by this paper
• Collection of alpha1-acid glycoprotein molecular species by capillary electrophoresis and the analysis of their molecular masses and carbohydrate chains. Basic studies on the analysis of glycoprotein glycoforms.

  2002cited by this paper
• Applicability of a modified Edman procedure for measurement of protein adducts: mechanisms of formation and degradation of phenylthiohydantoins.

  2002cited by this paper
• Identification of drug‐binding sites on human serum albumin using affinity capillary electrophoresis and chemically modified proteins as buffer additives

  2002cited by this paper
• Characterization of covalent adducts to intact cytochrome P450s by mass spectrometry.

  2002cited by this paper
• Covalent enzyme-substrate compounds: detection and catalytic competence.

  2002cited by this paper
• Proteomic approaches to characterize protein modifications: new tools to study the effects of environmental exposures.

  2002cited by this paper
• Summary of information on human CYP enzymes: human P450 metabolism data

  2002cited by this paper
• Sequence Mapping of Epoxide Adducts in Human Hemoglobin with LC−Tandem MS and the Salsa Algorithm

  2002cited by this paper
• Development of an in vitro screening model for the biosynthesis of acyl glucuronide metabolites and the assessment of their reactivity toward human serum albumin.

  2002cited by this paper
• Effect of tamoxifen on the enzymatic activity of human cytochrome CYP2B6.

  2002cited by this paper
• N-OXIDATIVE TRANSFORMATION OF FREE AND N-SUBSTITUTED AMINE FUNCTIONS BY CYTOCHROME P450 AS MEANS OF BIOACTIVATION AND DETOXICATION

  2002cited by this paper
• Sequence mapping of epoxide adducts in human hemoglobin with LC-tandem MS and the SALSA algorithm.

  2002cited by this paper
• Four decades of structure determination by mass spectrometry: From alkaloids to heparin

  2002cited by this paper
• Detection and identification of protein variants and adducts in blood and tissues: an application of soft ionization mass spectrometry to clinical diagnosis.

  2002cited by this paper
• Pharmacokinetics and Protein Adduct Formation of the Pharmacologically Active Acyl Glucuronide Metabolite of Mycophenolic Acid in Pediatric Renal Transplant Recipients

  2002cited by this paper
• Nmr in drug discovery

  2002cited by this paper
• Peptidyl aldehydes as reversible covalent inhibitors of protein tyrosine phosphatases.

  2002cited by this paper
• Drugs and the liver: advances in metabolism, toxicity, and therapeutics

  2002cited by this paper
• Structural characterization of chondroitin/dermatan sulfate oligosaccharides from bovine aorta by capillary electrophoresis and electrospray ionization quadrupole time-of-flight tandem mass spectrometry.

  2002cited by this paper
• Inhibition and possible induction of rat CYP2D after short‐ and long‐term treatment with antidepressants

  2002cited by this paper
• Drug hepatotoxicity.

  2002cited by this paper
• Improvement of in-gel digestion protocol for peptide mass fingerprinting by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

  2001cited by this paper
• Determination of the covalent adducts of the novel anti-cancer agent 5,6-dimethylxanthenone-4-acetic acid in biological samples by high-performance liquid chromatography.

  2001cited by this paper
• Observation of Covalent Intermediates in an Enzyme Mechanism at Atomic Resolution

  2001cited by this paper
• A novel approach for identification and measurement of hemoglobin adducts with 1,2,3,4-diepoxybutane by liquid chromatography/electrospray ionisation mass spectrometry and matrix-assisted laser desorption/ionisation tandem mass spectrometry.

  2001cited by this paper
• The Immunoassay Handbook

  2001cited by this paper
• HPLC/1H NMR spectroscopic studies of the reactive alpha-1-O-acyl isomer formed during acyl migration of S-naproxen beta-1-O-acyl glucuronide.

  2001cited by this paper
• Use of covalent binding in risk assessment.

  2001cited by this paper
• Monitoring 2-D gel-induced modifications of proteins by MALDI-TOF mass spectrometry.

  2001cited by this paper
• Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects.

  2001cited by this paper
• The Effects of Nitric Oxide on the Oxidations ofl-Dopa and Dopamine Mediated by Tyrosinase and Peroxidase*

  2001cited by this paper
• Reactive metabolites and their role in drug reactions

  2001cited by this paper
• Interindividual variability in human drug metabolism

  2001cited by this paper
• Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19.

  2001cited by this paper
• Mechanism-based inactivation of CYP2C11 by diclofenac.

  2001cited by this paper
• Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac.

  2001cited by this paper
• Use of isotopes and LC-MS-ESI-TOF for mechanistic studies of tienilic acid metabolic activation.

  2001cited by this paper
• Thyroid autoantibodies

  2001cited by this paper
• The computational prediction of toxicity.

  2001cited by this paper
• Capillary electrophoresis-mass spectrometric analysis of DNA adducts.

  2001cited by this paper
• Neutrophil Functions of Patients With Vasculitis Related to Myeloperoxidase-Specific Anti-Neutrophil Antibody

  2001cited by this paper
• An evaluation of the use of two-dimensional gel electrophoresis in proteomics.

  2001cited by this paper
• Reactive intermediates in biological systems: what have we learned and where are we going?

  2001cited by this paper
• Measurement of Acetaminophen‐Protein Adducts in Children and Adolescents with Acetaminophen Overdoses

  2001cited by this paper
• Protein analysis by capillary zone electrophoresis utilizing a trifunctional diamine for silica coating.

  2001cited by this paper
• Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles.

  2001cited by this paper
• Prediction of a new drug's potential to cause idiosyncratic reactions.

  2001cited by this paper
• Stationary phases for capillary electrophoresis and capillary electrochromatography

  2001cited by this paper
• Prediction of potential toxicity and side effect protein targets of a small molecule by a ligand-protein inverse docking approach.

  2001cited by this paper
• Differential selectivity in carbamazepine-induced inactivation of cytochrome P450 enzymes in rat and human liver

  2001cited by this paper
• Improvement of an in‐gel tryptic digestion method for matrix‐assisted laser desorption/ionization‐time of flight mass spectrometry peptide mapping by use of volatile solubilizing agents

  2001cited by this paper
• The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism*†

  2001cited by this paper
• Drug-Induced Liver Disorders

  2001cited by this paper
• Identification and reactivity of the major metabolite (ß-1-glucuronide) of the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in humans

  2001cited by this paper
• Protein Glycation

  2001cited by this paper
• Paracetamol (Acetaminophen)-Induced Toxicity: Molecular and Biochemical Mechanisms, Analogues and Protective Approaches

  2001cited by this paper

• Acrolein-Mediated Conversion of Lysine to Electrophilic Heterocycles for Protein Diversification and Toxicity Profiling

  2025cites this paper
• The Effects of Counter-Ions on Peptide Structure, Activity, and Applications

  2025cites this paper
• Covalent modification of proteins by osthole reactive metabolites using proteomic approaches.

  2023cites this paper
• Antipyretic Drug Candidates Through Reverse Docking Techniques Used In Science Learning

  2023cites this paper
• A Metabolic Activation-Based Chemoproteomic Platform to Profile Adducted Proteins Derived from Furan-Containing Compounds.

  2022cites this paper
• Significance of Multiple Bioactivation Pathways for Meclofenamate as Revealed through Modeling and Reaction Kinetics

  2020cites this paper
• Plasma treatment in air at atmospheric pressure that enables reagent-free covalent immobilization of biomolecules on polytetrafluoroethylene (PTFE)

  2020cites this paper
• Organ-Specific Screening for Protein Damage Using Magnetic Bead Bioreactors and LC-MS/MS.

  2020cites this paper
• Liquid Chromatography-Tandem Mass Spectrometry Analysis of Acetaminophen Covalent Binding to Glutathione S-Transferases

  2019cites this paper
• Plasma Ion Implantation of Silk Biomaterials Enabling Direct Covalent Immobilization of Bioactive Agents for Enhanced Cellular Responses.

  2018cites this paper
• Allergic reactions to β-lactam antibiotics: chemical approaches for improving in vitro diagnosis

  2018cites this paper
• Quantitative Chemical Proteomic Profiling of the in Vivo Targets of Reactive Drug Metabolites.

  2017cites this paper
• Plasma mediated protein immobilisation enhances the vascular compatibility of polyurethane with tissue matched mechanical properties

  2017cites this paper
• Drug-Protein Adducts: Chemistry, Mechanisms of Toxicity, and Methods of Characterization.

  2016cites this paper
• Identification of 4-hydroxynonenal protein targets in rat, mouse and human liver microsomes by two-dimensional liquid chromatography/tandem mass spectrometry.

  2016cites this paper
• Bioengineering Stents for Proactive Biocompatibility: From Biomaterials to Stents

  2015cites this paper
• High-resolution mass spectrometry-based background subtraction for identifying protein modifications in a complex biological system: detection of acetaminophen-bound microsomal proteins including argininosuccinate synthetase.

  2015cites this paper
• Identification of Acetaminophen Adducts of Rat Liver Microsomal Proteins using 2D-LC-MS/MS.

  2015cites this paper
• Identification of human liver microsomal proteins adducted by a reactive metabolite using shotgun proteomics.

  2014cites this paper
• Mechanistic Role of Acyl Glucuronides

  2013cites this paper
• Role of genetic polymorphisms of drug metabolising enzymes in idiosyncratic drug reactions In vitro to in vivo translation

  2013cites this paper
• Mechanism-based inhibition of CYP450: an indicator of drug-induced hepatotoxicity.

  2013cites this paper
• Identification and quantification of drug-albumin adducts in serum samples from a drug exposure study in mice.

  2013cites this paper
• Advances in drug-protein adduct analysis Using LC-MS based proteomics

  2013cites this paper
• Identification and pathway mapping of furan target proteins reveal mitochondrial energy production and redox regulation as critical targets of furan toxicity.

  2012cites this paper
• Identification of modification sites on human serum albumin and human hemoglobin adducts with houttuynin using liquid chromatography coupled with mass spectrometry.

  2012cites this paper
• Simulation of the oxidative metabolism of diclofenac by electrochemistry/(liquid chromatography/)mass spectrometry

  2012cites this paper
• Protein target discovery of drug and its reactive intermediate metabolite by using proteomic strategy

  2012cites this paper
• Proteomics in Drug Discovery and Development

  2012cites this paper
• Animal models of idiosyncratic drug-induced liver injury—Current status

  2011cites this paper
• Protein digestion optimization for characterization of drug-protein adducts using response surface modeling.

  2011cites this paper
• A comparison of covalent immobilization and physical adsorption of a cellulase enzyme mixture.

  2010cites this paper
• The linker-free covalent attachment of collagen to plasma immersion ion implantation treated polytetrafluoroethylene and subsequent cell-binding activity.

  2010cites this paper
• Bioactivation of Drugs by Cytochromes P450 : New Tools and Concepts for the Characterization of Reactive Metabolites of Drugs

  2009cites this paper
• Linker-free covalent attachment of the extracellular matrix protein tropoelastin to a polymer surface for directed cell spreading.

  2009cites this paper
• A targeted proteomics approach to the identification of peptides modified by reactive metabolites.

  2009cites this paper
• Acetylene plasma polymerized surfaces for covalent immobilization of dense bioactive protein monolayers

  2009cites this paper
• Covalent protein modification by reactive drug metabolites using online electrochemistry/liquid chromatography/mass spectrometry.

  2008cites this paper
• Production and Characterization of a Monoclonal Antibody to Capture Proteins Tagged with Lithocholic Acid

  2008cites this paper
• Antileishmanial 2-substituted quinolines: in vitro behaviour towards biological components.

  2007cites this paper
• The reactive metabolite target protein database (TPDB) – a web-accessible resource

  2007cites this paper
• Liquid Chromatography/Tandem Mass Spectrometry Detection of Covalent Binding of Acetaminophen to Human Serum Albumin

  2007cites this paper
• Trace analysis of proteins using postseparation solution-phase digestion and electrospray mass spectrometric detection of marker peptides.

  2007cites this paper
• Automated detection of covalent adducts to human serum albumin by immunoaffinity chromatography, on-line solution phase digestion and liquid chromatography-mass spectrometry.

  2007cites this paper
• LC-Tandem MS Detection of Covalent Binding of Acetaminophen to Human Serum Albumin.

  2007cites this paper
• A proteomic analysis of bromobenzene reactive metabolite targets in rat liver cytosol in vivo.

  2007cites this paper
• Indirect determination of pyruvic acid by capillary electrophoresis with amperometric detection.

  2007cites this paper
• Electrophoresis of pharmaceutical proteins: Status quo

  2006cites this paper
• Matrices for capillary gel electrophoresis--a brief overview of uncommon gels.

  2006cites this paper
• Two-dimensional gels for toxicological drug discovery applications

  2006cites this paper
• Detecting and characterizing reactive metabolites by liquid chromatography/tandem mass spectrometry.

  2006cites this paper
• Use of isotopic signatures for mass spectral detection of protein adduction by chemically reactive metabolites of bromobenzene: studies with model proteins.

  2005cites this paper
• Drug Bioactivation Covalent Binding to Target Proteins and Toxicity Relevance

  2005cites this paper
• Minimizing the potential for metabolic activation as an integral part of drug design.

  2005cites this paper
• Detection of covalent adducts to cytochrome P450 3A4 using liquid chromatography mass spectrometry.

  2004cites this paper
• Recent applications of affinity interactions in capillary electrophoresis

  2003cites this paper